尿激酶静脉溶栓治疗早期急性脑梗死的临床研究
 |
| 第1页 |
参见附件(268KB，2页)。
[摘要] 目的：探讨急性脑梗死尿激酶静脉溶栓治疗的临床疗效。方法：86例急性脑梗死病人随机分为溶栓组、对照组。溶栓组应用100万U尿激酶加入0.9%氯化钠溶液200 ml静滴, 30 min内滴完,溶栓12 h后用低分子肝素7 500 U皮下注射,1 次/24 h ,共5～7 d。对照组采用常规治疗方法。评价治疗前和治疗后24 h、2周及4周的神经功能缺损评分及临床疗效。结果：溶栓组临床疗效与对照组比较有显著性意义。结论：尿激酶静脉溶栓治疗早期急性脑梗死疗效好，相对安全。
[关键词] 急性脑梗死；尿激酶；静脉溶栓
[中图分类号] R743 [文献标识码]A [文章编号]1673-7210(2008)02(a)-039-02
The clinical study of urokinase in the therapy of thrombolysis in acute cerbral infarction
Song Li
(The Centeral Hospital of Liaoyang,Liaoyang 111000,China)
[Abstract] Objective:To evaluate the therapeutic effects of treating acute cerbral infarction with urokinase.Methods:86 patients with acute cerbral infarction were divided into thrombolysis group and control group.1 000 000 U of urokinase in 200 ml normal saline were administered via intravenous drip infusion within 30 min，7 500 U of low molecular heparin were administered via hypodermic injection 12 h after thrombolysis per 24 h , totally 5 to 7 days ......
您现在查看是摘要介绍页，详见PDF附件(268KB，2页)。